Mechanisms of Neuron Death in Neurodegenerative Diseases of the Elderly

[1]  J. Trojanowski,et al.  Monoclonal antibodies to purified cortical lewy bodies recognize the mid‐size neurofilament subunit , 1997, Annals of neurology.

[2]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[3]  M. Gurney,et al.  Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[4]  J Q Trojanowski,et al.  Selective Degeneration of Purkinje Cells with Lewy Body-Like Inclusions in Aged NFHLACZ Transgenic Mice , 1997, The Journal of Neuroscience.

[5]  M. Polymeropoulos,et al.  Mapping of a Gene for Parkinson's Disease to Chromosome 4q21-q23 , 1996, Science.

[6]  K. Kosaka,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.

[7]  J. Trojanowski,et al.  Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease. , 1996, The American journal of pathology.

[8]  M. Gurney,et al.  Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[9]  L. Forno,et al.  Neuropathology of Parkinson's Disease , 1996, Journal of neuropathology and experimental neurology.

[10]  D. Galasko,et al.  Neocortical Lewy Body Counts Correlate with Dementia in the Lewy Body Variant of Alzheimer's Disease , 1996, Journal of neuropathology and experimental neurology.

[11]  P. Blumbergs,et al.  Microtubule-associated protein 5 is a component of Lewy bodies and Lewy neurites in the brainstem and forebrain regions affected in Parkinson's disease , 1995, Acta Neuropathologica.

[12]  J. Brion,et al.  Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5. , 1995, The American journal of pathology.

[13]  T. Crawford,et al.  Increasing neurofilament subunit NF-M expression reduces axonal NF-H, inhibits radial growth, and results in neurofilamentous accumulation in motor neurons , 1995, The Journal of cell biology.

[14]  L. Chang,et al.  The Neuropathology of Parkinsonism - An Overview , 1995, Brain and Cognition.

[15]  L. Thal,et al.  Genetic-Evidence That the Lewy Body Variant Is Indeed a Phenotypic Variant of Alzheimers-Disease , 1995, Brain and Cognition.

[16]  J. Cummings.  Lewy Body Diseases with Dementia - Pathophysiology and Treatment , 1995, Brain and Cognition.

[17]  T. Yamada.  Further observations on MxA-positive Lewy bodies in Parkinson's disease brain tissues , 1995, Neuroscience Letters.

[18]  J. Trojanowski,et al.  Overexpression of the human NFM subunit in transgenic mice modifies the level of endogenous NFL and the phosphorylation state of NFH subunits , 1995, The Journal of cell biology.

[19]  J. Julien,et al.  Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis , 1995, Nature.

[20]  J. Julien,et al.  Mice overexpressing the human neurofilament heavy gene as a model of ALS , 1995, Neurobiology of Aging.

[21]  L. Han,et al.  Cortical Lewy bodies in Alzheimer's disease. , 1995, Archives of pathology & laboratory medicine.

[22]  E. Masliah,et al.  Fragmentation of the neuronal cytoskeleton in the Lewy body variant of Alzheimer's disease. , 1995, Neuroreport.

[23]  Akihiko Iwai,et al.  The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system , 1995, Neuron.

[24]  J. Trojanowski,et al.  Phosphorylation of Neuronal Cytoskeletal Proteins in Alzheimer's Disease and Lewy Body Dementias a , 1994, Annals of the New York Academy of Sciences.

[25]  J. Trojanowski,et al.  Modulation of axon diameter and neurofilaments by hypomyelinating Schwann cells in transgenic mice , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[26]  D. Cleveland,et al.  A mutant neurofilament subunit causes massive, selective motor neuron death: Implications for the pathogenesis of human motor neuron disease , 1994, Neuron.

[27]  T. Umahara,et al.  Cu Zn superoxide dismutase-like immunoreactivity in Lewy body-like inclusions of sporadic amyotrophic lateral sclerosis , 1994, Neuroscience Letters.

[28]  S. Ishiura,et al.  Multicatalytic proteinase is associated with characteristic oval structures in cortical Lewy bodies: an immunocytochemical study with light and electron microscopy , 1994, Journal of the Neurological Sciences.

[29]  A. Peterson,et al.  Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament-β-galactosidase fusion protein , 1994, Neuron.

[30]  J. Kimura,et al.  Synaptophysin and chromogranin A immunoreactivities of Lewy bodies in Parkinson's disease brains , 1994, Brain Research.

[31]  C. Lippa,et al.  Alzheimer's disease and Lewy body disease: A comparative clinicopathological study , 1994, Annals of neurology.

[32]  M. Swash,et al.  Antibody to an abnormal protein in amyotrophic lateral sclerosis identifies Lewy body-like inclusions in ALS and Lewy bodies in Parkinson's disease , 1993, Neuroscience Letters.

[33]  D. Dickson,et al.  Pathology and Biology of the Lewy Body , 1993, Journal of neuropathology and experimental neurology.

[34]  J. Julien,et al.  Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis , 1993, Cell.

[35]  L. Cork,et al.  Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease , 1993, Cell.

[36]  C. Bergeron,et al.  Deposition of detergent-resistant neurofilaments into Lewy body fibrils , 1993, Brain Research.

[37]  A. Lees,et al.  A clinicopathologic study of 100 cases of Parkinson's disease. , 1993, Archives of neurology.

[38]  R. Nixon,et al.  The Regulation of Neurofilament Protein Dynamics by Phosphorylation: Clues to Neurofibrillary Pathobiology , 1993, Brain pathology.

[39]  J. Trojanowski,et al.  Altered Tau and Neurofilament Proteins in Neuro‐Degenerative Diseases: Diagnostic Implications for Alzheimer's Disease and Lewy Body Dementias , 1993, Brain pathology.

[40]  J. Trojanowski,et al.  Lewy bodies contain beta-amyloid precursor proteins of Alzheimer's disease , 1992, Brain Research.

[41]  M S Pollanen,et al.  Detergent‐Insoluble Cortical Lewy Body Fibrils Share Epitopes with Neurofilament and τ , 1992, Journal of neurochemistry.

[42]  K. Obata,et al.  Immunocytochemical localization of synaptic vesicle-specific protein in lewy body-containing neurons in Parkinson's disease , 1992, Neuroscience Letters.

[43]  P. Mulvihill,et al.  Filaments of Lewy bodies contain insoluble cytoskeletal elements. , 1992, The American journal of pathology.

[44]  P. Ince,et al.  Topography, Extent, and Clinical Relevance of Neurochemical Deficits in Dementia of Lewy Body Type, Parkinson's Disease, and Alzheimer's Disease , 1991, Annals of the New York Academy of Sciences.

[45]  P. Ince,et al.  Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: Comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients , 1991, Journal of the Neurological Sciences.

[46]  V. Lee,et al.  Individual neurofilament subunits reassembled in vitro exhibit unique biochemical, morphological and immunological properties , 1991, Brain Research.

[47]  P. Mcgeer,et al.  Two Types of Spheroid Bodies in the Nigral Neurons in Parkinson's Disease , 1991, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[48]  J. Trojanowski,et al.  Epitopes located in spatially separate domains of each neurofilament subunit are present in parkinson's disease lewy bodies , 1991, The Journal of comparative neurology.

[49]  T. Wisniewski,et al.  Lewy bodies are immunoreactive with antibodies raised to gelsolin related amyloid-Finnish type. , 1991, The American journal of pathology.

[50]  D. Selkoe.  The molecular pathology of Alzheimer's disease , 1991, Neuron.

[51]  L. Wolfson,et al.  Antemortem diagnosis of diffuse Lewy body disease , 1990, Neurology.

[52]  P. Mcgeer,et al.  Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K , 1990, Brain Research.

[53]  J. Lowe,et al.  Dementia with β-amyloid deposition: involvement of αB-crystallin supports two main diseases , 1990, The Lancet.

[54]  J. Lowe,et al.  Ubiquitin carboxyl‐terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases , 1990, The Journal of pathology.

[55]  Robert H. Perry,et al.  Senile dementia of Lewy body type A clinically and neuropathologically distinct form of Lewy body dementia in the elderly , 1990, Journal of the Neurological Sciences.

[56]  L. Thal,et al.  The Lewy body variant of Alzheimer's disease , 1990, Neurology.

[57]  P. Lantos,et al.  Cortical Lewy body dementia: clinical features and classification. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[58]  L. Otvos,et al.  Identification of the major multiphosphorylation site in mammalian neurofilaments. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[59]  E. Hirsch,et al.  Characterization of two antigens in parkinsonian Lewy bodies , 1988, Brain Research.

[60]  J. Trojanowski,et al.  Monoclonal antibodies distinguish several differentially phosphorylated states of the two largest rat neurofilament subunits (NF-H and NF-M) and demonstrate their existence in the normal nervous system of adult rats , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[61]  V. Lee,et al.  Phosphate dependent and independent neurofilament epitopes in the axonal swellings of patients with motor neuron disease and controls. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[62]  W. Poewe,et al.  THE CENTENARY OF FRIEDERICH H. LEWY 1885–1950 , 1986, Neuropathology and applied neurobiology.

[63]  L. Forno,et al.  Reaction of Lewy bodies with antibodies to phosphorylated and non-phosphorylated neurofilaments , 1986, Neuroscience Letters.

[64]  J. Goldman,et al.  Cytoskeletal protein abnormalities in neurodegenerative diseases , 1986, Annals of neurology.

[65]  F. Ikuta,et al.  Tyrosine hydroxylase protein in Lewy bodies of parkinsonian and senile brains , 1984, Journal of the Neurological Sciences.

[66]  L. Sternberger,et al.  Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[67]  J. Goldman,et al.  Lewy bodies of Parkinson's disease contain neurofilament antigens. , 1983, Science.

[68]  V. Tennyson,et al.  Phase and Electron Microscopic Observations of Lewy Bodies and Melanin Granules in the Substantia Nigra and Locus Caeruleus in Parkinson's Disease , 1965 .

[69]  L. Lipkin,et al.  DIFFUSE INTRACYTOPLASMIC GANGLIONIC INCLUSIONS (LEWY TYPE) ASSOCIATED WITH PROGRESSIVE DEMENTIA AND QUADRIPARESIS IN FLEXION , 1961, Journal of neuropathology and experimental neurology.

[70]  John A. Martin,et al.  Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer’s disease and Lewy body disorders , 1996, Acta Neuropathologica.

[71]  L. Thal,et al.  The spectrum of diseases with diffuse Lewy bodies. , 1995, Advances in neurology.

[72]  J Q Trojanowski,et al.  Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies. , 1991, The American journal of pathology.

[73]  K. Maclennan,et al.  Intermediate filament-ubiquitin diseases: implications for cell sanitization. , 1989, Biochemical Society symposium.